← Back to all trials
Completed
NCT05164705
Improving Human Cerebrovascular Function Using Acute Intermittent Hypoxia
Conditions: Healthy Brain Perfusion
Sex: All
Ages: 21 Years – 50 Years
Healthy volunteers: Yes
Phase: NA
Enrollment: 33
Sponsor: Northwestern University
Location: Northwestern University Chicago Illinois
Summary
This study uses magnetic resonance imaging to determine whether 3 weeks of repeated exposure to Acute Intermittent Hypoxia can improve brain blood flow or blood flow regulation in healthy adults.
Eligibility Criteria
Inclusion Criteria:
* Healthy volunteers between ages of 21 and 50 years
* No known neurological, respiratory or vascular conditions
* Safe to be scanned using MRI
* Able to communicate in English
Exclusion Criteria:
* MRI contraindications as indicated on MRI safety screening form
* Subjects with pacemakers, cochlear (in the ear) implants, or aneurysm clips or subjects who have worked with metal
* Pregnant women
* Individuals with known neurological or vascular conditions
* Individuals with sleep apnea, emphysema, or other respiratory conditions
* Individuals with severe claustrophobia
* Subjects unwilling or unable to give written informed consent in English
* Prisoners
* Frequent smoker
* Allergy to Tegaderm
* Blood pressure greater than 140/90 or less than 90/55.
* Individuals who report headaches, feeling dizzy or light-headed, or have heart palpitations on the day of the study.
* Individuals prescribed Aripiprazole and/or Lamotrigine\*
Note, mild (well-controlled) asthma is not immediate grounds for exclusion.
\*Other prescription medications may be grounds for exclusion; prescription medication information will be acquired during initial screening and at subsequent follow-up visits
Source: ClinicalTrials.gov (NCT05164705). StuddyBuddy aggregates publicly available trial information.